Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina A phase II randomized, double-blinded, placebo-controlled study

Informations projet

ReGenHeart

N° de convention de subvention: 731532

DOI 10.3030/731532

Projet clôturé

Date de signature de la CE 1 Decembre 2016

Date de début 1 Janvier 2017

Date de fin 31 Decembre 2022

Financé au titre de

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coût total € 5 934 088,75

Contribution de l’UE € 5 934 086,00

Coordonné par

POHJOIS-SAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
Finland

Livrables

Documents, reports (2)

Summary report on project management methods used during the project
Summary report on ethical & gender issues raised by the project

Summary report on ethical gender issues raised by the project

Websites, patent fillings, videos etc. (1)

Project website